Jun 24 |
Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?
|
Jun 3 |
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
May 16 |
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
|
May 15 |
Spero Therapeutics GAAP EPS of -$0.24 misses by $0.20, revenue of $9.26M misses by $12.27M
|
May 15 |
Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
|
May 14 |
Spero Therapeutics Q1 2024 Earnings Preview
|
May 10 |
Shareholders in Spero Therapeutics (NASDAQ:SPRO) are in the red if they invested three years ago
|
May 8 |
Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024
|
May 1 |
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Apr 23 |
Spero Therapeutics Delivers On Game Plan To Create Shareholder Value
|